This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
MP Materials (MP) Surges 21.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
MP Materials (MP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
MPPositive Net Change TECKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Janux Therapeutics (JANX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
JANXNegative Net Change STOKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Brookdale (BKD) Stock Jumps 9.4%: Will It Continue to Soar?
by Zacks Equity Research
Brookdale (BKD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BKDNegative Net Change ENSGNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength?
by Zacks Equity Research
Wave Life Sciences (WVE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
WVENegative Net Change LCTXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
FuelCell Energy (FCEL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
FCELPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
A-Mark Precious Metals (AMRK) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AMRKNo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Priority Technology (PRTH) Surges 5.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Priority Technology (PRTH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
PRTHNegative Net Change OWLTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Aquestive Therapeutics (AQST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
AQSTNegative Net Change MDGLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Oculis Holding AG (OCS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
OCSNegative Net Change QGENNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Radcom (RDCM) Soars 5.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Radcom (RDCM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RDCMNegative Net Change NTCTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Energy Fuels (UUUU) Surges 9.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Energy Fuels (UUUU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
UUUUPositive Net Change CDENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
ams-OSRAM AG Unsponsored ADR (AMSSY) Surges 11.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
ams-OSRAM AG Unsponsored ADR (AMSSY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
AMSSYNegative Net Change SQNSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Confluent (CFLT): Can Its 7.6% Jump Turn into More Strength?
by Zacks Equity Research
Confluent (CFLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CFLTPositive Net Change SEMRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Solaris Energy Infrastructure, Inc. (SEI) Moves 9.4% Higher: Will This Strength Last?
by Zacks Equity Research
Solaris Energy Infrastructure, Inc. (SEI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
SEIPositive Net Change USACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Voyager Therapeutics (VYGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
VYGRNegative Net Change ALVONegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Septerna, Inc. (SEPN): Can Its 7.0% Jump Turn into More Strength?
by Zacks Equity Research
Septerna, Inc. (SEPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
SEPNNegative Net Change GYRENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TopBuild (BLD) Moves 10.1% Higher: Will This Strength Last?
by Zacks Equity Research
TopBuild (BLD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BLDNegative Net Change HLMNNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Vir Biotechnology (VIR) Surges 6.9%: Is This an Indication of Further Gains?
by Zacks Equity Research
Vir Biotechnology (VIR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
VIRNegative Net Change TARSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
STOKNegative Net Change JANXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Intellia Therapeutics (NTLA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NTLANegative Net Change ACIUNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Tyler Technologies (TYL) Soars 6.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Tyler Technologies (TYL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TYLNegative Net Change GLOBNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Endeavour Silver (EXK) Moves 6.9% Higher: Will This Strength Last?
by Zacks Equity Research
Endeavour Silver (EXK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
EXKNegative Net Change PAASNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Nexa Resources (NEXA) Soars 5.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Nexa Resources (NEXA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
NEXANegative Net Change MUXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
CRISPR Therapeutics (CRSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CRSPNegative Net Change PBYINegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
IREN Limited (IREN) Moves 6.8% Higher: Will This Strength Last?
by Zacks Equity Research
IREN Limited (IREN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
IRENNegative Net Change SOFIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today